指派 发表于 2025-3-28 14:57:10
Laboratory Monitoring: HIV, TB and Hepatitis, for TB, HBV, and HCV is necessary prior to treatment with a biologic agent. Prescreening for HIV is advised in patients with risk factors. The presence of chronic infection does not preclude treatment with a biologic therapy; however, these patients must be followed closely by an interdisciplinary team to ensure the best possible outcomes.造反,叛乱 发表于 2025-3-28 20:36:41
http://reply.papertrans.cn/19/1873/187288/187288_42.png低三下四之人 发表于 2025-3-28 23:56:36
http://reply.papertrans.cn/19/1873/187288/187288_43.png好色 发表于 2025-3-29 03:32:52
Laboratory Monitoring: HIV, TB and Hepatitis,herapy can pose potential risks for patients with concomitant chronic infections including human immunodeficiency virus (HIV), tuberculosis (TB), hepatitis B (HBV), and hepatitis C (HCV). To date, many of these drugs have not been thoroughly studied for patients with chronic infections. Prescreening极小量 发表于 2025-3-29 10:57:34
http://reply.papertrans.cn/19/1873/187288/187288_45.pngArrhythmia 发表于 2025-3-29 13:44:14
http://reply.papertrans.cn/19/1873/187288/187288_46.pngStress-Fracture 发表于 2025-3-29 15:36:00
http://reply.papertrans.cn/19/1873/187288/187288_47.pngamorphous 发表于 2025-3-29 21:07:35
Combination Therapy with Biologic Agents, the advent of various biologic agents for the treatment of moderate-to-severe psoriasis, it is now possible for many patients to achieve adequate disease control with subsequent improvement in quality of life. However, in some circumstances, combining a biologic agent with one or more additional thBronchial-Tubes 发表于 2025-3-30 02:51:32
http://reply.papertrans.cn/19/1873/187288/187288_49.png转换 发表于 2025-3-30 07:13:02
http://reply.papertrans.cn/19/1873/187288/187288_50.png